Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

BACKGROUND: Mesenchymal stromal cells (MSC) may serve as an attractive therapy in renal transplantation due to their immunosuppressive and reparative properties. While most studies have used autologous MSCs, allogeneic MSCs offer the advantage of immediate availability for clinical use. This is of m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Reinders, Marlies E. J., Dreyer, Geertje J., Bank, Jonna R., Roelofs, Helene, Heidt, Sebastiaan, Roelen, Dave L., Zandvliet, Maarten L., Huurman, Volkert A. L., Fibbe, Wim E., van Kooten, Cees, Claas, Frans H. J., Rabelink, Ton J., de Fijter, Johan W.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4632480/
https://ncbi.nlm.nih.gov/pubmed/26537851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0700-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados